GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » EV-to-Revenue

Luyan Pharma Co (SZSE:002788) EV-to-Revenue : 0.40 (As of May. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Luyan Pharma Co's enterprise value is ¥8,041 Mil. Luyan Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥20,140 Mil. Therefore, Luyan Pharma Co's EV-to-Revenue for today is 0.40.

The historical rank and industry rank for Luyan Pharma Co's EV-to-Revenue or its related term are showing as below:

SZSE:002788' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.35   Med: 0.42   Max: 1.5
Current: 0.4

During the past 13 years, the highest EV-to-Revenue of Luyan Pharma Co was 1.50. The lowest was 0.35. And the median was 0.42.

SZSE:002788's EV-to-Revenue is ranked better than
88.5% of 661 companies
in the Healthcare Providers & Services industry
Industry Median: 1.82 vs SZSE:002788: 0.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Luyan Pharma Co's stock price is ¥8.75. Luyan Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥52.13. Therefore, Luyan Pharma Co's PS Ratio for today is 0.17.


Luyan Pharma Co EV-to-Revenue Historical Data

The historical data trend for Luyan Pharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co EV-to-Revenue Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.40 0.41 0.40 0.39

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.42 0.44 0.39 0.39

Competitive Comparison of Luyan Pharma Co's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Luyan Pharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luyan Pharma Co's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Luyan Pharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Luyan Pharma Co's EV-to-Revenue falls into.



Luyan Pharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Luyan Pharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8040.896/20139.712
=0.40

Luyan Pharma Co's current Enterprise Value is ¥8,041 Mil.
Luyan Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥20,140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luyan Pharma Co  (SZSE:002788) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Luyan Pharma Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8.75/52.127
=0.17

Luyan Pharma Co's share price for today is ¥8.75.
Luyan Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥52.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luyan Pharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Luyan Pharma Co (SZSE:002788) Business Description

Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines